Lately, the market has been tough all around but perhaps not so bad as the pounding taken over the past eight months by COVID vaccine company Moderna (Moderna Stock Quote, Charts, News, Analysts, Financials NASDAQ:MRNA), which has seen its share price drop more than 70 per cent of its value over that period. But investors […]
Rahul Sarugaser of Raymond James likes the story around HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:HLS), maintaining his “Outperform 2” rating and raising his target price from $26/share to $28/share for a projected return of 104.4 per cent in an update to his clients on Monday. Toronto-based specialty pharma company HLS […]
Share
Tweet
Share
